SCHEMBL7652997

SCHEMBL7652997

O=C(NCCO)c1cncc(C(=O)NCCO)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.59
POLB P06746 4/20 0.59
GAA P10253 1/20 0.59
ATM Q13315 1/20 0.56
ALDH1A1 P00352 4/20 0.53
HPGD P15428 3/20 0.53
HTT P42858 1/20 0.51
NTRK2 Q16620 1/20 0.51
PKM P14618 1/20 0.50
ITGB3 P05106 1/20 0.47
ITGA2B P08514 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13279530 0.88 KDM4E (0.53) KDM4EPOLBGAAATMALDH1A1
SCHEMBL13852632 0.88 HCAR2 (0.53) KDM4EPOLBGAAATMALDH1A1
SCHEMBL31533961 0.88 PKM (0.67) KDM4EPOLBALDH1A1HTTPKM
SCHEMBL15228268 0.88 PKM (0.67) KDM4EPOLBALDH1A1HTTPKM
SCHEMBL3321012 0.85 NTRK2 (0.65) KDM4EPOLBALDH1A1HPGDHTT
SCHEMBL23015835 0.85 SMYD3 (0.56) KDM4EPOLBGAAATMALDH1A1
SCHEMBL10671308 0.84 POLB (0.47) KDM4EPOLBGAAATMALDH1A1
SCHEMBL13466415 0.84 KDM4E (0.48) KDM4EPOLBGAAATMALDH1A1
SCHEMBL13741510 0.84 PKM (0.48) KDM4EPOLBGAAATMALDH1A1
SCHEMBL5909197 0.83 THRB (0.61) KDM4EPOLBGAAATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed